Biotech VC boutique obtains Finma licence

A venture capital firm targeting private biotechnology companies has received a portfolio manager licence from Finma. Pureos Partners announced the news on Wednesday. It is supervised by the Organisation de surveillance financière supervisory authority. Pureos is based in Pfäffikon, canton Schwyz. Its investments include Swiss eye disease therapy developer NovaGo…